LCI133
LCI133 is an innovative, highly potent, and selective multi-target kinase inhibitor effective at the nanomolar level. It targets CDK4/6/9 and AURKA/B with IC50 values of 4.7/10.2/4.1 nM and 2.8/10.6 nM, respectively. In MYCN-amplified neuroblastoma BE (2) -C cells, LCI133 induces S/G2 phase arrest and triggers significant apoptosis (apoptosis) . Moreover, LCI133 demonstrates substantial antitumor efficacy in BE (2) -C neuroblastoma xenograft models.
Product Specifications
CAS Number
3065284-87-6
Smiles
O=C1C=C (OC2=CC (=CC=C12) C=3C=CC (=CC3) NC=4N=CC=5C=C (C (=O) N (C) C) N (C5N4) C6CCCC6) N7CCOCC7
Molecular Formula
C33H34N6O4
Molecular Weight
578.67
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2570949 200 µL
Purple sea urchin PKS1 Rabbit Polyclonal Antibody (FITC)
Sign In for Pricing
View Details